| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | Arkowitz David | Chief Financial Officer | Feb 16, 2024 | Sale | $1.08 | 3,939 | 4,254 | 182,442 | Feb 16, 2024, 09:13 PM | |
| MCRB | Seres Therapeutics, Inc. | Arkowitz David | Chief Financial Officer | Oct 30, 2023 | Sale | $1.35 | 4,066 | 5,489 | 175,756 | Oct 31, 2023, 09:39 PM | |
| FSTX | F-star Therapeutics, Inc. | Arkowitz David | Director | Mar 08, 2023 | Option Exercise | $7.12 | 8,386 | 59,708 | 0 | Mar 09, 2023, 09:10 AM | |
| MCRB | Seres Therapeutics, Inc. | Arkowitz David | Chief Financial Officer | Jul 05, 2022 | Option Exercise | $3.15 | 63,492 | 200,000 | 65,492 | Jul 06, 2022, 07:23 PM | |
| FLXN | Flexion Therapeutics Inc | Arkowitz David | Chief Financial Officer | May 10, 2021 | Sale | $7.23 | 2,229 | 16,116 | 220,719 | May 12, 2021, 05:06 PM | |
| FLXN | Flexion Therapeutics Inc | Arkowitz David | Chief Financial Officer | Jan 05, 2021 | Sale | $11.13 | 6,073 | 67,592 | 151,048 | Jan 07, 2021, 05:50 PM | |
| YMTX | YUMANITY THERAPEUTICS, INC. | Arkowitz David | Director | Dec 22, 2020 | Option Exercise | $23.00 | 4,347 | 99,981 | 4,347 | Dec 28, 2020, 07:05 PM | |
| FLXN | Flexion Therapeutics Inc | Arkowitz David | Chief Financial Officer | Jun 22, 2020 | Option Exercise | $10.83 | 1,303 | 14,111 | 118,371 | Jun 24, 2020, 04:21 PM | |
| FLXN | Flexion Therapeutics Inc | Arkowitz David | Chief Financial Officer | May 07, 2020 | Sale | $10.88 | 2,413 | 26,253 | 117,068 | May 11, 2020, 04:11 PM | |
| FLXN | Flexion Therapeutics Inc | Arkowitz David | Chief Financial Officer | Jun 21, 2019 | Option Exercise | $9.81 | 2,152 | 21,111 | 91,576 | Jun 24, 2019, 04:10 PM | |
| FLXN | Flexion Therapeutics Inc | Arkowitz David | Chief Financial Officer | May 31, 2019 | Buy | $11.05 | 2,500 | 27,627 | 89,424 | Jun 03, 2019, 04:18 PM | |
| FLXN | Flexion Therapeutics Inc | Arkowitz David | Chief Financial Officer | May 13, 2019 | Buy | $11.99 | 4,000 | 47,960 | 86,924 | May 15, 2019, 04:05 PM | |
| FLXN | Flexion Therapeutics Inc | Arkowitz David | Chief Financial Officer | May 08, 2019 | Sale | $10.06 | 2,248 | 22,615 | 82,924 | May 09, 2019, 04:32 PM | |
| FLXN | Flexion Therapeutics Inc | Arkowitz David | Chief Financial Officer | Dec 20, 2018 | Option Exercise | $10.48 | 922 | 9,663 | 49,172 | Jan 04, 2019, 05:07 PM | |
| FLXN | Flexion Therapeutics Inc | Arkowitz David | Chief Financial Officer | Nov 09, 2018 | Buy | $16.56 | 4,000 | 66,222 | 48,250 | Nov 13, 2018, 09:14 AM | |
| FLXN | Flexion Therapeutics Inc | Arkowitz David | Chief Financial Officer | Aug 09, 2018 | Buy | $23.42 | 4,000 | 93,680 | 44,250 | Aug 10, 2018, 12:56 PM | |
| SBPH | Spring Bank Pharmaceuticals, Inc. | Arkowitz David | Director | Aug 04, 2017 | Buy | $12.24 | 2,500 | 30,602 | 19,386 | Aug 07, 2017, 04:02 PM | |
| SBPH | Spring Bank Pharmaceuticals, Inc. | Arkowitz David | Director | Nov 23, 2016 | Option Exercise | $9.12 | 4,386 | 40,000 | 16,886 | Nov 23, 2016, 04:00 PM | |
| AMAG | AMAG PHARMACEUTICALS INC. | Arkowitz David | EVP, CFO, CBO | May 31, 2011 | Buy | $13.23 | 1,500 | 19,845 | 1,806 | Jun 01, 2011, 04:35 PM | |
| AMAG | AMAG PHARMACEUTICALS INC. | Arkowitz David | EVP, CFO and CBO | May 31, 2011 | Buy | $13.23 | 1,500 | 19,845 | 1,806 | Jun 01, 2011, 04:01 PM | |
| AMAG | AMAG PHARMACEUTICALS INC. | Arkowitz David | EVP, Chief Financial Officer | Feb 24, 2011 | Sale | $17.07 | 2,705 | 46,167 | 2,511 | Feb 28, 2011, 04:03 PM |
Menu